Compare ETV & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Current Price
| Metric | ETV | AZTA |
|---|---|---|
| Founded | N/A | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Industrial Machinery/Components |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2005 | 1996 |
| Metric | ETV | AZTA |
|---|---|---|
| Price | $13.70 | $20.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $42.60 |
| AVG Volume (30 Days) | 171.6K | ★ 826.8K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $593,821,000.00 |
| Revenue This Year | N/A | $6.52 |
| Revenue Next Year | N/A | $5.67 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.64 | $20.22 |
| 52 Week High | $14.83 | $41.73 |
| Indicator | ETV | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 28.23 | 21.98 |
| Support Level | $13.55 | N/A |
| Resistance Level | $14.03 | $32.18 |
| Average True Range (ATR) | 0.21 | 1.15 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 1.44 | 0.08 |
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.